Eczacibasi-Monrol (now acquired by Curium Pharma) is a global radiopharmaceutical company headquartered in Istanbul, Turkey, with 13 facilities across Eastern Europe, Middle East, and Africa regions. The company provides CDMO services for radiopharmaceutical development and manufacturing, including PET and SPECT products, and is one of the world's largest Lutetium-177 producers.
Radiopharmaceutical manufacturing, Lutetium-177 production, PET radiopharmaceuticals, SPECT products, Gallium-68 generators, Theranostics
2 sites worldwide
No certifications on file yet.
No reviews available yet.
No documents available.